still doesn't make sense to me. rib majorly increases SVR compared to monotherapy, and while RVR may be a good predictor of SVR, most patients with gen-1 who go on to SVR do NOT achieve RVR - so why would anyone conclude that rib's primary moa is via improving RVR?